CARE Ratings Nepal assigns BB- and A4 to long term and short term bank facilities of Everest Parenternals; Registered with DDA with Neha Agrawal as major promoter

CARE Ratings Nepal Limited (CRNL) has assigned rating of ‘CARE-NP BB-’ to the long-term bank facilities and ‘CARE-NP A4’ to the short-term bank facilities of Everest Parenterals Private Limited (EPPL).               

Key Rating Weaknesses

• Competition from existing players and exposure to foreign currency exchange risk
• Working capital intensive nature of business
• Project stabilization risk and marketability risk
• Exposure to regulatory risk
• Exposure to volatile interest rate.

Key Rating Strengths

• Promoter and management having experience in related field
• Financial closure achieved for the full project cost
• Demand of pharmaceuticals products

About the Company

Everest Parenterals Private Limited (EPPL) is a Private Limited company, incorporated as on January 6, 2010 and is registered with DDA. It is promoted by Mrs. Neha Agrawal for setting up a unit for manufacturing of injectables largely known as Large Volume Parenterals (LVP) and Small Volume Parenterals (SVP). EPPL belongs to Everest Healthcare Group which is part of Ranasaria Group which is having investments in various sectors. SVP will include products like Vials, Ampoules and Eye/ Ear drops in different sizes ranging from 1ml to 30ml whereas LVP will include different Saline and Solution products in packaging of Polypropylene Bottles and Non-Polyvinyl Chloride Flexi Bag in different size ranging from 100ml to 1000ml.

Details of the Facilities rated

Source: https://careratingsnepal.com/

Read the full report here.